F6Publishing

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Articles Published Processes

Keyword: hepatic steatosis

Page 1 of 2 ( 67 items )
<<
1
2
>>

1	Impact of metabolic dysfunction-associated steatotic liver disease on liver metastasis and survival in pancreatic cancer 3/16/2026 8:22:56 AM \| Browse: 78 \| Download: 345
2	Evaluation methods of hepatic steatosis: From conventional techniques to emerging biomarkers 1/27/2026 10:12:31 AM \| Browse: 131 \| Download: 428
3	Gluten’s silent strike: Unmasking its impact on liver health 12/22/2025 7:43:02 AM \| Browse: 121 \| Download: 447
4	Fatty liver reexamined choline and mitochondrial toxin amelioration 12/4/2025 6:40:47 AM \| Browse: 179 \| Download: 362
5	Machine learning to predict metabolic-associated fatty liver disease 12/3/2025 9:10:07 AM \| Browse: 158 \| Download: 517
6	Bile acids in metabolic dysfunction-associated steatotic liver disease 8/27/2025 9:21:12 AM \| Browse: 363 \| Download: 623
7	Nutrients as epigenetic modulators in metabolic dysfunction-associated steatotic liver disease 8/27/2025 9:21:11 AM \| Browse: 333 \| Download: 663
8	Copper and hepatic lipid dysregulation: Mechanisms and implications 8/27/2025 9:21:08 AM \| Browse: 280 \| Download: 507
9	Duodenal mucosal ablation: An emerging therapeutic concept for metabolic dysfunction-associated fatty liver disease 7/24/2025 7:47:21 AM \| Browse: 146 \| Download: 476
10	Machine learning-based identification of biochemical markers to predict hepatic steatosis in patients at high metabolic risk 7/21/2025 9:42:33 AM \| Browse: 139 \| Download: 608
11	Extracellular vesicles as biomarkers for metabolic dysfunction-associated steatotic liver disease staging using explainable artificial intelligence 6/12/2025 3:45:50 AM \| Browse: 207 \| Download: 972
12	Bicuculline ameliorates metabolic dysfunction-associated steatotic liver disease by inhibiting the nuclear factor-kappa B pathway and reducing lipid accumulation 4/29/2025 9:13:41 AM \| Browse: 175 \| Download: 901
13	Correlation of liver imaging and transient elastography among patients with hepatitis C at a safety net hospital 4/25/2025 8:23:05 AM \| Browse: 292 \| Download: 729
14	Role of 1,25-dihydroxyvitamin D3 in alleviating hepatic steatosis: Targeting M1 macrophage polarization in non-alcoholic fatty liver disease 2/14/2025 10:33:16 AM \| Browse: 281 \| Download: 818
15	Inhibition of metabotropic glutamate receptor-5 alleviates hepatic steatosis by enhancing autophagy via activation of the AMPK signaling pathway 1/20/2025 7:38:46 AM \| Browse: 247 \| Download: 728
16	Pathogenesis and research progress of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis 10/21/2024 7:03:24 AM \| Browse: 235 \| Download: 809
17	Hepatoprotective effects of Xiaoyao San formula on hepatic steatosis and inflammation via regulating the sex hormones metabolism 7/26/2024 10:33:30 AM \| Browse: 317 \| Download: 1336
18	Liver disease in patients with transfusion-dependent β-thalassemia: The emerging role of metabolism dysfunction-associated steatotic liver disease 5/22/2024 11:33:24 AM \| Browse: 163 \| Download: 776
19	Two-point Dixon and six-point Dixon magnetic resonance techniques in the detection, quantification and grading of hepatic steatosis 10/24/2023 7:40:57 AM \| Browse: 334 \| Download: 1163
20	Peroxisome proliferator-activated receptors as targets to treat metabolic diseases: Focus on the adipose tissue, liver, and pancreas 7/10/2023 8:58:21 AM \| Browse: 591 \| Download: 1487
21	Non-invasive evaluation of liver steatosis with imaging modalities: New techniques and applications 5/7/2023 7:47:34 AM \| Browse: 642 \| Download: 1461
22	Metabolic dysfunction associated fatty liver disease: The new nomenclature and its impact 1/12/2023 10:19:09 AM \| Browse: 643 \| Download: 1662
23	Hepatic steatosis with mass effect: A case report 10/21/2022 2:24:59 AM \| Browse: 714 \| Download: 2375
24	Interplay between metabolic dysfunction-associated fatty liver disease and chronic kidney disease: Epidemiology, pathophysiologic mechanisms, and treatment considerations 10/18/2022 8:29:59 AM \| Browse: 896 \| Download: 1597
25	Growing challenge of post-liver transplantation non-alcoholic fatty liver disease 9/13/2022 3:28:02 AM \| Browse: 881 \| Download: 2018
26	Nonalcoholic fatty liver disease and diabetes 9/9/2022 3:45:24 PM \| Browse: 1000 \| Download: 1941
27	Higher cardiovascular risk scores and liver fibrosis risk estimated by biomarkers in patients with metabolic-dysfunction-associated fatty liver disease 8/26/2022 9:51:35 AM \| Browse: 897 \| Download: 1726
28	Metabolic dysfunction is associated with steatosis but no other histologic features in nonalcoholic fatty liver disease 4/30/2022 5:08:22 AM \| Browse: 865 \| Download: 2248
29	Testosterone therapy reduces hepatic steatosis in men with type 2 diabetes and low serum testosterone concentrations 4/22/2022 10:52:23 AM \| Browse: 872 \| Download: 1864
30	Hepatobiliary manifestations in inflammatory bowel disease: A practical approach 2/22/2022 9:25:37 AM \| Browse: 598 \| Download: 1569
31	Influencing factors for hepatic fat accumulation in patients with type 2 diabetes mellitus 9/10/2021 7:23:16 AM \| Browse: 757 \| Download: 2313
32	Metabolic and cardiovascular complications after virological cure in hepatitis C: What awaits beyond 4/29/2021 2:12:02 AM \| Browse: 903 \| Download: 1912
33	Evaluation of controlled attenuation parameter in assessing hepatic steatosis in patients with autoimmune liver diseases 12/30/2020 1:59:10 PM \| Browse: 1003 \| Download: 2609
34	MANF ameliorates steatosis in HepG2 cells by regulating hepatic lipid metabolism 3/14/2020 3:03:29 PM \| Browse: 1274 \| Download: 2692
35	Allyl isothiocyanate ameliorates lipid accumulation and inflammation in nonalcoholic fatty liver disease via the Sirt1/AMPK and NF-κB signaling pathways 9/12/2019 8:50:34 AM \| Browse: 980 \| Download: 2904
36	Accuracy of multi-echo Dixon sequence in quantification of hepatic steatosis in Chinese children and adolescents 3/28/2019 9:14:41 AM \| Browse: 1374 \| Download: 2858
37	Ursodeoxycholic acid ameliorates hepatic lipid metabolism in LO2 cells by regulating the AKT/mTOR/SREBP-1 signaling pathway 3/28/2019 9:14:40 AM \| Browse: 1399 \| Download: 2537
38	Hemodynamic changes in hepatic sinusoids of hepatic steatosis mice 3/20/2019 5:32:10 AM \| Browse: 1453 \| Download: 2843
39	Risk factors for hepatic steatosis in adults with cystic fibrosis: Similarities to non-alcoholic fatty liver disease 1/26/2018 8:09:36 AM \| Browse: 1091 \| Download: 2408
40	Clinical epidemiology and disease burden of nonalcoholic fatty liver disease 12/20/2017 2:49:19 AM \| Browse: 1898 \| Download: 2395
41	Fatty liver without a large “belly”: Magnified review of non-alcoholic fatty liver disease in non-obese patients 8/14/2017 1:56:00 AM \| Browse: 1527 \| Download: 2498
42	S-1 induced hepatic steatosis in patients with pancreatic cancer: Retrospective analysis 8/10/2017 11:54:13 PM \| Browse: 1739 \| Download: 2845
43	Is hepatic steatosis associated with left ventricular mass index increase in the general population? 7/5/2017 4:40:08 AM \| Browse: 1381 \| Download: 3039
44	Antioxidant dietary approach in treatment of fatty liver: New insights and updates 6/20/2017 12:12:52 PM \| Browse: 1613 \| Download: 2816
45	Embrionary way to create a fatty liver in portal hypertension 5/16/2017 6:56:36 AM \| Browse: 1748 \| Download: 3393
46	Chronic exposure to ethanol causes steatosis and inflammation in zebrafish liver 3/13/2017 1:20:00 PM \| Browse: 1513 \| Download: 2296
47	Sitagliptin in patients with non-alcoholic steatohepatitis: A randomized, placebo-controlled trial 1/5/2017 11:10:00 AM \| Browse: 1970 \| Download: 3971
48	Quality of life 10 years after liver transplantation: The impact of graft histology 12/14/2016 2:15:00 PM \| Browse: 1487 \| Download: 1992
49	Hepatic steatosis and fibrosis: Non-invasive assessment 12/6/2016 5:24:00 PM \| Browse: 1621 \| Download: 2182
50	Retrospective study of the associations between hepatitis C virus infection and metabolic factors 10/25/2016 8:46:00 AM \| Browse: 1954 \| Download: 3366

Page 1 of 2 ( 67 items )
<<
1
2
>>

1	Impact of metabolic dysfunction-associated steatotic liver disease on liver metastasis and survival in pancreatic cancer 3/16/2026 8:22:56 AM \| Browse: 78 \| Download: 345
2	Evaluation methods of hepatic steatosis: From conventional techniques to emerging biomarkers 1/27/2026 10:12:31 AM \| Browse: 131 \| Download: 428
3	Gluten’s silent strike: Unmasking its impact on liver health 12/22/2025 7:43:02 AM \| Browse: 121 \| Download: 447
4	Fatty liver reexamined choline and mitochondrial toxin amelioration 12/4/2025 6:40:47 AM \| Browse: 179 \| Download: 362
5	Machine learning to predict metabolic-associated fatty liver disease 12/3/2025 9:10:07 AM \| Browse: 158 \| Download: 517
6	Bile acids in metabolic dysfunction-associated steatotic liver disease 8/27/2025 9:21:12 AM \| Browse: 363 \| Download: 623
7	Nutrients as epigenetic modulators in metabolic dysfunction-associated steatotic liver disease 8/27/2025 9:21:11 AM \| Browse: 333 \| Download: 663
8	Copper and hepatic lipid dysregulation: Mechanisms and implications 8/27/2025 9:21:08 AM \| Browse: 280 \| Download: 507
9	Duodenal mucosal ablation: An emerging therapeutic concept for metabolic dysfunction-associated fatty liver disease 7/24/2025 7:47:21 AM \| Browse: 146 \| Download: 476
10	Machine learning-based identification of biochemical markers to predict hepatic steatosis in patients at high metabolic risk 7/21/2025 9:42:33 AM \| Browse: 139 \| Download: 608
11	Extracellular vesicles as biomarkers for metabolic dysfunction-associated steatotic liver disease staging using explainable artificial intelligence 6/12/2025 3:45:50 AM \| Browse: 207 \| Download: 972
12	Bicuculline ameliorates metabolic dysfunction-associated steatotic liver disease by inhibiting the nuclear factor-kappa B pathway and reducing lipid accumulation 4/29/2025 9:13:41 AM \| Browse: 175 \| Download: 901
13	Correlation of liver imaging and transient elastography among patients with hepatitis C at a safety net hospital 4/25/2025 8:23:05 AM \| Browse: 292 \| Download: 729
14	Role of 1,25-dihydroxyvitamin D3 in alleviating hepatic steatosis: Targeting M1 macrophage polarization in non-alcoholic fatty liver disease 2/14/2025 10:33:16 AM \| Browse: 281 \| Download: 818
15	Inhibition of metabotropic glutamate receptor-5 alleviates hepatic steatosis by enhancing autophagy via activation of the AMPK signaling pathway 1/20/2025 7:38:46 AM \| Browse: 247 \| Download: 728
16	Pathogenesis and research progress of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis 10/21/2024 7:03:24 AM \| Browse: 235 \| Download: 809
17	Hepatoprotective effects of Xiaoyao San formula on hepatic steatosis and inflammation via regulating the sex hormones metabolism 7/26/2024 10:33:30 AM \| Browse: 317 \| Download: 1336
18	Liver disease in patients with transfusion-dependent β-thalassemia: The emerging role of metabolism dysfunction-associated steatotic liver disease 5/22/2024 11:33:24 AM \| Browse: 163 \| Download: 776
19	Two-point Dixon and six-point Dixon magnetic resonance techniques in the detection, quantification and grading of hepatic steatosis 10/24/2023 7:40:57 AM \| Browse: 334 \| Download: 1163
20	Peroxisome proliferator-activated receptors as targets to treat metabolic diseases: Focus on the adipose tissue, liver, and pancreas 7/10/2023 8:58:21 AM \| Browse: 591 \| Download: 1487
21	Non-invasive evaluation of liver steatosis with imaging modalities: New techniques and applications 5/7/2023 7:47:34 AM \| Browse: 642 \| Download: 1461
22	Metabolic dysfunction associated fatty liver disease: The new nomenclature and its impact 1/12/2023 10:19:09 AM \| Browse: 643 \| Download: 1662
23	Hepatic steatosis with mass effect: A case report 10/21/2022 2:24:59 AM \| Browse: 714 \| Download: 2375
24	Interplay between metabolic dysfunction-associated fatty liver disease and chronic kidney disease: Epidemiology, pathophysiologic mechanisms, and treatment considerations 10/18/2022 8:29:59 AM \| Browse: 896 \| Download: 1597
25	Growing challenge of post-liver transplantation non-alcoholic fatty liver disease 9/13/2022 3:28:02 AM \| Browse: 881 \| Download: 2018
26	Nonalcoholic fatty liver disease and diabetes 9/9/2022 3:45:24 PM \| Browse: 1000 \| Download: 1941
27	Higher cardiovascular risk scores and liver fibrosis risk estimated by biomarkers in patients with metabolic-dysfunction-associated fatty liver disease 8/26/2022 9:51:35 AM \| Browse: 897 \| Download: 1726
28	Metabolic dysfunction is associated with steatosis but no other histologic features in nonalcoholic fatty liver disease 4/30/2022 5:08:22 AM \| Browse: 865 \| Download: 2248
29	Testosterone therapy reduces hepatic steatosis in men with type 2 diabetes and low serum testosterone concentrations 4/22/2022 10:52:23 AM \| Browse: 872 \| Download: 1864
30	Hepatobiliary manifestations in inflammatory bowel disease: A practical approach 2/22/2022 9:25:37 AM \| Browse: 598 \| Download: 1569
31	Influencing factors for hepatic fat accumulation in patients with type 2 diabetes mellitus 9/10/2021 7:23:16 AM \| Browse: 757 \| Download: 2313
32	Metabolic and cardiovascular complications after virological cure in hepatitis C: What awaits beyond 4/29/2021 2:12:02 AM \| Browse: 903 \| Download: 1912
33	Evaluation of controlled attenuation parameter in assessing hepatic steatosis in patients with autoimmune liver diseases 12/30/2020 1:59:10 PM \| Browse: 1003 \| Download: 2609
34	MANF ameliorates steatosis in HepG2 cells by regulating hepatic lipid metabolism 3/14/2020 3:03:29 PM \| Browse: 1274 \| Download: 2692
35	Allyl isothiocyanate ameliorates lipid accumulation and inflammation in nonalcoholic fatty liver disease via the Sirt1/AMPK and NF-κB signaling pathways 9/12/2019 8:50:34 AM \| Browse: 980 \| Download: 2904
36	Accuracy of multi-echo Dixon sequence in quantification of hepatic steatosis in Chinese children and adolescents 3/28/2019 9:14:41 AM \| Browse: 1374 \| Download: 2858
37	Ursodeoxycholic acid ameliorates hepatic lipid metabolism in LO2 cells by regulating the AKT/mTOR/SREBP-1 signaling pathway 3/28/2019 9:14:40 AM \| Browse: 1399 \| Download: 2537
38	Hemodynamic changes in hepatic sinusoids of hepatic steatosis mice 3/20/2019 5:32:10 AM \| Browse: 1453 \| Download: 2843
39	Risk factors for hepatic steatosis in adults with cystic fibrosis: Similarities to non-alcoholic fatty liver disease 1/26/2018 8:09:36 AM \| Browse: 1091 \| Download: 2408
40	Clinical epidemiology and disease burden of nonalcoholic fatty liver disease 12/20/2017 2:49:19 AM \| Browse: 1898 \| Download: 2395
41	Fatty liver without a large “belly”: Magnified review of non-alcoholic fatty liver disease in non-obese patients 8/14/2017 1:56:00 AM \| Browse: 1527 \| Download: 2498
42	S-1 induced hepatic steatosis in patients with pancreatic cancer: Retrospective analysis 8/10/2017 11:54:13 PM \| Browse: 1739 \| Download: 2845
43	Is hepatic steatosis associated with left ventricular mass index increase in the general population? 7/5/2017 4:40:08 AM \| Browse: 1381 \| Download: 3039
44	Antioxidant dietary approach in treatment of fatty liver: New insights and updates 6/20/2017 12:12:52 PM \| Browse: 1613 \| Download: 2816
45	Embrionary way to create a fatty liver in portal hypertension 5/16/2017 6:56:36 AM \| Browse: 1748 \| Download: 3393
46	Chronic exposure to ethanol causes steatosis and inflammation in zebrafish liver 3/13/2017 1:20:00 PM \| Browse: 1513 \| Download: 2296
47	Sitagliptin in patients with non-alcoholic steatohepatitis: A randomized, placebo-controlled trial 1/5/2017 11:10:00 AM \| Browse: 1970 \| Download: 3971
48	Quality of life 10 years after liver transplantation: The impact of graft histology 12/14/2016 2:15:00 PM \| Browse: 1487 \| Download: 1992
49	Hepatic steatosis and fibrosis: Non-invasive assessment 12/6/2016 5:24:00 PM \| Browse: 1621 \| Download: 2182
50	Retrospective study of the associations between hepatitis C virus infection and metabolic factors 10/25/2016 8:46:00 AM \| Browse: 1954 \| Download: 3366